arginine vasopressin has been researched along with cyclosporine in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (56.25) | 18.2507 |
2000's | 3 (18.75) | 29.6817 |
2010's | 4 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hardy, KJ; Phillips, PA; Potocnik, SJ | 1 |
Braith, RW; Limacher, MC; Lowenthal, DT; Phillips, MI; Pollock, ML; Staples, ED; Wood, CE | 1 |
Bronsther, O; Brown, MR; Crum, R; Dominic, W; Fairchild, R; Fernandez, R; Ward, D | 1 |
Dominice, C; Dufour, MN; Grazzini, E; Guillon, G; Jouin, P; Manzoni, O; Patino, N | 1 |
Bokemeyer, D; Drechsler, S; Friedrichs, U; Kramer, HJ; Meyer-Lehnert, H | 1 |
Eckert, B; Knepel, W; Schwaninger, M | 1 |
Braith, RW; Davis, GL; Mills, RM; Wilcox, CS; Wood, CE | 1 |
Byrnes, AP; Conde, G; Geddes, BJ; Harding, TC; Hughes, DS; Lightman, SL; Uney, JB | 1 |
Thomas, M; Tyagi, MG | 1 |
Brandis, M; Epting, T; Fischer-Riepe, P; Gordjani, N; Greger, RF; Leipziger, J; Nitschke, R | 1 |
Avdonin, PV; Buetler, TM; Cottet-Maire, F; Mermod, N; Roulet, E; Ruegg, UT | 1 |
Shang, FJ; Wang, JP; Zhao, LY; Zheng, QS | 1 |
Bachmann, S; Bader, M; Blankenstein, KI; Boldt, C; Borschewski, A; Ellison, DH; Labes, R; McCormick, JA; Mutig, K; Paliege, A | 1 |
1 review(s) available for arginine vasopressin and cyclosporine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for arginine vasopressin and cyclosporine
Article | Year |
---|---|
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Human resistance artery reactivity is altered by liver transplantation and treatment with cyclosporin A.
Topics: Adipose Tissue; Angiotensin II; Arginine Vasopressin; Arteries; Cyclosporine; Humans; In Vitro Techniques; Liver Neoplasms; Liver Transplantation; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Vascular Resistance; Vasoconstriction | 1992 |
Abnormal neuroendocrine responses during exercise in heart transplant recipients.
Topics: Afferent Pathways; Arginine Vasopressin; Atrial Natriuretic Factor; Cyclosporine; Exercise; Exercise Test; Female; Heart; Heart Transplantation; Humans; Hypertension; Kidney; Male; Mechanoreceptors; Middle Aged; Neurosecretory Systems; Norepinephrine; Renin-Angiotensin System | 1992 |
Neuroendocrinology of chronic renal failure and renal transplantation.
Topics: Adult; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Cyclosporine; Epinephrine; Furosemide; Humans; Hypertension, Renal; Kidney Failure, Chronic; Kidney Transplantation; Methylprednisolone; Neurosecretory Systems; Norepinephrine; Prospective Studies; Radioimmunoassay; Renal Dialysis; Water-Electrolyte Balance | 1991 |
Dual effects of nordidemnin on WRK1 cells: inhibition of phosphoinositide metabolism and cell proliferation.
Topics: Animals; Antibiotics, Antineoplastic; Arginine Vasopressin; Calcium; Cell Division; Cyclosporine; Depsipeptides; Female; Inositol; Peptides, Cyclic; Phosphatidylinositols; Rats; Tumor Cells, Cultured; Type C Phospholipases | 1994 |
Cellular signaling by cyclosporine A in contractile cells: interactions with atrial natriuretic peptide.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Calcium; Cells, Cultured; Cyclosporine; Glomerular Mesangium; Male; Muscle Contraction; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Signal Transduction | 1993 |
Calcium-mobilizing insulin secretagogues stimulate transcription that is directed by the cyclic adenosine 3',5'-monophosphate/calcium response element in a pancreatic islet beta-cell line.
Topics: Animals; Arginine Vasopressin; Biological Transport; Calcium; Cell Line; Cricetinae; Cyclic AMP Response Element-Binding Protein; Cyclosporine; Insulin; Insulin Secretion; Islets of Langerhans; Phosphorylation; Tacrolimus; Transcription, Genetic | 1996 |
Breakdown of blood pressure and body fluid homeostasis in heart transplant recipients.
Topics: Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Case-Control Studies; Cyclosporine; Female; Heart; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Renin-Angiotensin System; Sodium Chloride; Sodium, Dietary; Ventricular Function, Left; Water-Electrolyte Balance; Water-Electrolyte Imbalance | 1996 |
Persistent transgene expression in the hypothalamus following stereotaxic delivery of a recombinant adenovirus: suppression of the immune response with cyclosporin.
Topics: Adenoviruses, Human; Animals; Arginine Vasopressin; beta-Galactosidase; Cell Line; Cyclosporine; Gene Expression; Genes, Reporter; Humans; Immunosuppression Therapy; Male; Paraventricular Hypothalamic Nucleus; Rats; Rats, Inbred WKY; Stereotaxic Techniques; Transfection | 1996 |
Enhanced cardiovascular reactivity to desmopressin in water-restricted rats: facilitatory role of immunosuppression.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Cardiovascular System; Cyclosporine; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Drug Synergism; Heart Rate; Hemodynamics; Immunosuppression Therapy; Immunosuppressive Agents; Infusions, Intra-Arterial; Infusions, Intravenous; Rats; Tacrolimus; Time Factors; Water Deprivation | 1999 |
Cyclosporin-A-induced effects on the free Ca2+ concentration in LLC-PK1-cells and their mechanisms.
Topics: Adenosine Triphosphate; Animals; Arginine Vasopressin; Biological Transport; Calcineurin Inhibitors; Calcium; Cyclosporine; Estrenes; Fluorescent Dyes; Fura-2; Immunosuppressive Agents; Inositol 1,4,5-Trisphosphate; Kidney Tubules, Proximal; LLC-PK1 Cells; Nicardipine; Phosphodiesterase Inhibitors; Pyrrolidinones; Renal Agents; Signal Transduction; Swine; Tacrolimus; Type C Phospholipases; Vasodilator Agents | 2000 |
Upregulation of vasopressin V1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment.
Topics: Animals; Arginine Vasopressin; Cells, Cultured; Cyclosporine; Heterogeneous Nuclear Ribonucleoprotein D0; Heterogeneous-Nuclear Ribonucleoprotein D; Immunosuppressive Agents; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred WKY; Receptors, Vasopressin; RNA-Binding Proteins; RNA, Messenger; Up-Regulation | 2001 |
Inhibitory effect of cyclosporin A on growth and collagen synthesis of rat cardiac fibroblasts induced by arginine vasopressin.
Topics: Animals; Animals, Newborn; Arginine Vasopressin; Calcineurin; Cell Cycle; Cell Proliferation; Cell Survival; Cells, Cultured; Collagen; Cyclosporine; Dose-Response Relationship, Drug; Fibroblasts; Hydroxyproline; Myocardium; Rats; Rats, Sprague-Dawley | 2006 |
Calcineurin inhibitor cyclosporine A activates renal Na-K-Cl cotransporters via local and systemic mechanisms.
Topics: Animals; Arginine Vasopressin; Calcineurin Inhibitors; Cells, Cultured; Cyclooxygenase 2; Cyclosporine; Epithelial Cells; Hypertension; Immunosuppressive Agents; Kidney Tubules, Distal; Loop of Henle; Male; Rats, Brattleboro; Rats, Wistar; Renin; Solute Carrier Family 12, Member 1; Solute Carrier Family 12, Member 3; Time Factors; Water-Electrolyte Balance | 2017 |